Cargando…
Discovery of Novel Imidazopyridine GSK-3β Inhibitors Supported by Computational Approaches
The interest of research groups and pharmaceutical companies to discover novel GSK-3β inhibitors has increased over the years considering the involvement of this enzyme in many pathophysiological processes and diseases. Along this line, we recently reported on 1H-indazole-3-carboxamide (INDZ) deriva...
Autores principales: | Buonfiglio, Rosa, Prati, Federica, Bischetti, Martina, Cavarischia, Claudia, Furlotti, Guido, Ombrato, Rosella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248956/ https://www.ncbi.nlm.nih.gov/pubmed/32380735 http://dx.doi.org/10.3390/molecules25092163 |
Ejemplares similares
-
Discovery of Novel Chemical Series of OXA-48 β-Lactamase Inhibitors by High-Throughput Screening
por: Garofalo, Barbara, et al.
Publicado: (2021) -
Substituted imidazopyridines as potent inhibitors of HCV replication()
por: Vliegen, Inge, et al.
Publicado: (2009) -
Testing Fmr1(KO) Phenotypes in Response to GSK3 Inhibitors: SB216763 versus AFC03127
por: Westmark, Pamela R., et al.
Publicado: (2021) -
Recent Developments in the Photochemical Synthesis of Functionalized Imidazopyridines
por: Tran, Christine, et al.
Publicado: (2022) -
Machine Learning for Discovery of GSK3β Inhibitors
por: Vignaux, Patricia A., et al.
Publicado: (2020)